The usual palliative treatment of inoperable carcinoma of the prostate results in an average survival of 2.5 years. To improve this, new approaches to therapy were explored by the authors. This monograph deals with the treatment of prostatic carcinoma with radioactive colloidal gold. The cases that mainly concerned the authors were those in which the cancer had spread beyond the prostate gland. While surgery is the main, and irradiation only the occasional, method of therapy, it is suggested that a combination of the two may give the best results. This should particularly apply to interstitial irradiation with radioactive gold and surgery.
The details of the authors' technique are well presented. From the clinical material, it was discovered that the group of patients with early prostatic cancers fall into two categories, namely, those with and those without lymph node involvement. Ten per cent of the radioactivity was detected in uninvolved lymph